AdvertisementFDA Decision Signals New Competition For Some Of The Costliest DrugsMarch 10, 2015Elana GordonfacebookEmailA look inside the factory in Kundl, Austria, where Sandoz, a unit of Novartis, makes biosimilar drugs. (Novartis)
